| Dr Bradley David Hodapp, DO | |
|
3124 Wilmington Rd, New Castle, PA 16105-1100 | |
| (724) 658-3020 | |
| Not Available |
| Full Name | Dr Bradley David Hodapp |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Adult Medicine |
| Location | 3124 Wilmington Rd, New Castle, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326668161 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | OS022678 (Pennsylvania) | Primary |
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
In the same week that physicians at the University of California-San Francisco medical center were wiping down and reusing protective equipment like masks and gowns to conserve resources amid a surge of COVID-19 patients, 90 miles away teams of doctors at UC Davis Medical Center were fully suited up performing breast augmentations, hip replacements and other elective procedures that likely could have been postponed.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced interim results of CLL-009, a study evaluating three starting doses of REVLIMID (lenalidomide), followed by step-wise dose escalation as tolerated in patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Full-Service Partnerships are designed to do 'whatever it takes' to improve residential stability and mental health outcomes for homeless persons with serious mental illness. They are the cornerstone of California's Mental Health Services Act - one of the largest mental health policy experiments in recent history.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley David Hodapp, DO 3124 Wilmington Rd Ste 401, New Castle, PA 16105-1100 Ph: (724) 658-3020 | Dr Bradley David Hodapp, DO 3124 Wilmington Rd, New Castle, PA 16105-1100 Ph: (724) 658-3020 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
In the same week that physicians at the University of California-San Francisco medical center were wiping down and reusing protective equipment like masks and gowns to conserve resources amid a surge of COVID-19 patients, 90 miles away teams of doctors at UC Davis Medical Center were fully suited up performing breast augmentations, hip replacements and other elective procedures that likely could have been postponed.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced interim results of CLL-009, a study evaluating three starting doses of REVLIMID (lenalidomide), followed by step-wise dose escalation as tolerated in patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Full-Service Partnerships are designed to do 'whatever it takes' to improve residential stability and mental health outcomes for homeless persons with serious mental illness. They are the cornerstone of California's Mental Health Services Act - one of the largest mental health policy experiments in recent history.
› Verified 1 days ago
Jane Kelley, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 149 Enclave Dr, Suite 101, New Castle, PA 16105 Phone: 724-598-8777 | |
Dr. Joann H Lamb, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 188 Enclave Dr, New Castle, PA 16105 Phone: 724-657-3220 Fax: 724-657-3223 | |
Anthony J Elisco, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1112 S Mill St, New Castle, PA 16101 Phone: 724-658-4564 Fax: 724-657-8563 | |
Maritoni Cynthia Malvar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 178 Enclave Dr, New Castle, PA 16105 Phone: 724-658-7765 | |
Dr. David R Shober, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Wilmington Rd, New Castle, PA 16105 Phone: 724-658-7550 Fax: 724-658-7551 | |
Ben Brian Ong, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Wilmington Rd, New Castle, PA 16105 Phone: 724-658-7550 Fax: 734-658-7551 |